No abstract available
MeSH terms
-
Acarbose / adverse effects
-
Acarbose / pharmacology
-
Acarbose / therapeutic use*
-
Arteriosclerosis / etiology
-
Arteriosclerosis / prevention & control
-
Carbohydrate Metabolism
-
Diabetes Mellitus, Type 2 / etiology
-
Diabetes Mellitus, Type 2 / prevention & control
-
Enzyme Inhibitors / adverse effects
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / therapeutic use*
-
Glucose Intolerance / complications
-
Glucose Intolerance / drug therapy*
-
Glucose Intolerance / physiopathology
-
Glycoside Hydrolase Inhibitors*
-
Humans
-
Hyperglycemia / complications
-
Hyperglycemia / drug therapy*
-
Hyperglycemia / physiopathology
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use*
-
Insulin Resistance
-
Intestinal Absorption / drug effects
-
Postprandial Period
-
Primary Prevention
Substances
-
Enzyme Inhibitors
-
Glycoside Hydrolase Inhibitors
-
Hypoglycemic Agents
-
Acarbose